CBD may aid in reducing inflammation during wound healing and soft tissue recovery by limiting excessive cytokines and promoting resolution. Clinical case reports and reviews support accelerated healing.
In patients with epidermolysis bullosa, self-initiated topical CBD led to faster wound healing, reduced blistering, and pain relief (Chelliah et al., 2018). A systematic review of cannabinoid use in chronic wounds reported complete closure with CBD-containing formulations (Niyangoda et al., 2024).
Topical CBD also improved inflammatory skin parameters and scarring in related conditions (Palmieri et al., 2019). This evidence suggests CBD's utility in managing inflammation for tissue repair.
References
-
Chelliah, M. P., et al. (2018). Self-initiated use of topical cannabidiol oil for epidermolysis bullosa. Pediatric Dermatology, 35(4), e224–e227. https://doi.org/10.1111/pde.13545
-
Niyangoda, D., et al. (2024). Cannabinoids in integumentary wound care: A systematic review of emerging preclinical and clinical evidence. Pharmaceutics, 16(8), 1081. https://doi.org/10.3390/pharmaceutics16081081
-
Palmieri, B., Vadala, M., & Romano, B. (2019). A therapeutic effect of CBD-enriched ointment in inflammatory skin diseases and cutaneous scars. La Clinica Terapeutica, 170(2), e93–e99. https://doi.org/10.7417/CT.2019.2116
